ZA965367B - A pharmaceutical formulation - Google Patents
A pharmaceutical formulationInfo
- Publication number
- ZA965367B ZA965367B ZA965367A ZA965367A ZA965367B ZA 965367 B ZA965367 B ZA 965367B ZA 965367 A ZA965367 A ZA 965367A ZA 965367 A ZA965367 A ZA 965367A ZA 965367 B ZA965367 B ZA 965367B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical formulation
- formulation
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH] (Somatotropin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88195P | 1995-07-12 | 1995-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA965367B true ZA965367B (en) | 1997-01-23 |
Family
ID=21693419
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA965367A ZA965367B (en) | 1995-07-12 | 1996-06-25 | A pharmaceutical formulation |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0837690A1 (en) |
| JP (1) | JPH11510483A (en) |
| KR (1) | KR19990028908A (en) |
| CN (1) | CN1190896A (en) |
| AU (1) | AU699850B2 (en) |
| BR (1) | BR9609573A (en) |
| CA (1) | CA2226553A1 (en) |
| CZ (1) | CZ6198A3 (en) |
| HU (1) | HUP9802286A3 (en) |
| IL (1) | IL122519A0 (en) |
| NO (1) | NO980103D0 (en) |
| PL (1) | PL324386A1 (en) |
| WO (1) | WO1997002833A1 (en) |
| ZA (1) | ZA965367B (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100236393B1 (en) * | 1996-02-02 | 1999-12-15 | 나까니시 히로유끼 | A pharmaceutical preparation containing a human growth hormone |
| US6566329B1 (en) | 1999-06-28 | 2003-05-20 | Novo Nordisk A/S | Freeze-dried preparation of human growth hormone |
| KR20030038690A (en) | 2000-08-07 | 2003-05-16 | 인헤일 테라퓨틱 시스템즈 인크. | Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation |
| AU2003289317A1 (en) * | 2002-12-11 | 2004-06-30 | Santen Pharmaceutical Co., Ltd. | Preservative for ophthalmology |
| CN103751769B (en) * | 2013-12-25 | 2015-08-19 | 楼秀余 | A kind of lyophilizing recombinant human somatropin capsule and preparation method thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816568A (en) * | 1986-05-16 | 1989-03-28 | International Minerals & Chemical Corp. | Stabilization of growth hormones |
| DK204791D0 (en) * | 1991-12-20 | 1991-12-20 | Novo Nordisk As | UNKNOWN PHARMACEUTICAL PREPARATION |
| DE10399015I1 (en) * | 1991-12-20 | 2012-05-03 | Novo Nordisk As | Stabilized pharmaceutical formulation containing growth hormone and histidine |
| EP0805689A1 (en) * | 1995-01-13 | 1997-11-12 | Novo Nordisk A/S | A stabilized pharmaceutical formulation comprising a growth hormone and x-lys |
-
1996
- 1996-06-25 ZA ZA965367A patent/ZA965367B/en unknown
- 1996-06-28 IL IL12251996A patent/IL122519A0/en unknown
- 1996-06-28 CN CN96195465A patent/CN1190896A/en active Pending
- 1996-06-28 KR KR1019980700210A patent/KR19990028908A/en not_active Application Discontinuation
- 1996-06-28 AU AU63533/96A patent/AU699850B2/en not_active Ceased
- 1996-06-28 PL PL96324386A patent/PL324386A1/en unknown
- 1996-06-28 JP JP9505422A patent/JPH11510483A/en active Pending
- 1996-06-28 CZ CZ9861A patent/CZ6198A3/en unknown
- 1996-06-28 WO PCT/DK1996/000290 patent/WO1997002833A1/en not_active Application Discontinuation
- 1996-06-28 BR BR9609573A patent/BR9609573A/en not_active Application Discontinuation
- 1996-06-28 CA CA002226553A patent/CA2226553A1/en not_active Abandoned
- 1996-06-28 EP EP96922774A patent/EP0837690A1/en not_active Withdrawn
- 1996-06-28 HU HU9802286A patent/HUP9802286A3/en unknown
-
1998
- 1998-01-09 NO NO980103A patent/NO980103D0/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU699850B2 (en) | 1998-12-17 |
| CA2226553A1 (en) | 1997-01-30 |
| BR9609573A (en) | 1999-03-02 |
| AU6353396A (en) | 1997-02-10 |
| JPH11510483A (en) | 1999-09-14 |
| NO980103L (en) | 1998-01-09 |
| NO980103D0 (en) | 1998-01-09 |
| PL324386A1 (en) | 1998-05-25 |
| IL122519A0 (en) | 1998-06-15 |
| EP0837690A1 (en) | 1998-04-29 |
| MX9800309A (en) | 1998-07-31 |
| HUP9802286A3 (en) | 1999-06-28 |
| CN1190896A (en) | 1998-08-19 |
| CZ6198A3 (en) | 1998-06-17 |
| HUP9802286A2 (en) | 1999-02-01 |
| KR19990028908A (en) | 1999-04-15 |
| WO1997002833A1 (en) | 1997-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA965368B (en) | A pharmaceutical formulation | |
| ZA96124B (en) | A pharmaceutical formulation | |
| GB9519363D0 (en) | Pharmaceutical formulation | |
| EG23826A (en) | Pharmaceutical formulations | |
| GB9523752D0 (en) | Pharmaceutical formulations | |
| GB9407386D0 (en) | Pharmaceutical formulation | |
| GB9402203D0 (en) | Pharmaceutical formulation | |
| IL112521A0 (en) | Pharmaceutical formulation | |
| EP0862431A4 (en) | Pharmaceutical formulation | |
| ZA958606B (en) | A pharmaceutical formulation | |
| EP0850057A4 (en) | Pharmaceutical compounds | |
| GB9405856D0 (en) | Pharmaceutical formulation | |
| GB9416599D0 (en) | Pharmaceutical formulation | |
| GB9523566D0 (en) | Pharmaceutical formulation | |
| ZA96526B (en) | Novel pharmaceutical formulation | |
| AU3949093A (en) | A pharmaceutical formulation | |
| ZA964372B (en) | A pharmaceutical formulation | |
| ZA965367B (en) | A pharmaceutical formulation | |
| AP9801196A0 (en) | Pharmaceutical preparation | |
| ZA96122B (en) | A pharmaceutical formulation | |
| HU9603498D0 (en) | Pharmaceutical compounds | |
| ZA96392B (en) | Pharmaceutical formulations | |
| ZA96123B (en) | A pharmaceutical formulation | |
| GB9500978D0 (en) | Pharmaceutical formulations | |
| GB9502786D0 (en) | Pharmaceutical formulation |